Evidence map›Paper›PMID 22438798›Full record

ArticlePLoS computational biology2012

Conformational control of the binding of the transactivation domain of the MLL protein and c-Myb to the KIX domain of CREB.

Elif Nihal Korkmaz, Ruth Nussinov, Türkan Haliloğlu

Abstract read
In one paragraph

Article in PLoS computational biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Fluorine-Thiol Displacement Stapling on the Disordered αSynlett : accounts and rapid communications in synthetic organic chemistry · 2025
    Article
  4. Article
  5. Article
  6. Structural basis for cooperative regulation of KIX-mediated transcription pathways by the HTLV-1 HBZ activation domain.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  7. Review
  8. Review
  9. NMR Methods to Study Dynamic Allostery.PLoS computational biology · 2016
    Review
  10. Article
  11. Review
  12. Allosteric Dynamic Control of Binding.Biophysical journal · 2015
    Article
  13. Principles of allosteric interactions in cell signaling.Journal of the American Chemical Society · 2014
    Review
  14. Review
  15. Allostery within a transcription coactivator is predominantly mediated through dissociation rate constants.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  16. Prepaying the entropic cost for allosteric regulation in KIX.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  17. Dissecting allosteric effects of activator-coactivator complexes using a covalent small molecule ligand.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elif Nihal KorkmazPolymer Research Center & Chemical Engineering Department, Boğaziçi University, Istanbul, Turkey.
Ruth Nussinov
Türkan Haliloğlu

Funding

Protein Structure, Stability, and Amyloid FormationZIABC010440 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSINOV, RUTH · 2009 to 2025
$11.8M
Biomolecular Recognition and Binding MechanismsZIABC010441 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI NUSSINOV, RUTH · 2009 to 2025
$9.4M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

The KIX domain of CBP is a transcriptional coactivator. Concomitant binding to the activation domain of proto-oncogene protein c-Myb and the transactivation domain of the trithorax group protein mixed lineage leukemia (MLL) transcription factor lead to the biologically active ternary MLL∶KIX∶c-Myb complex which plays a role in Pol II-mediated transcription. The binding of the activation domain of MLL to KIX enhances c-Myb binding. Here we carried out molecular dynamics (MD) simulations for the MLL∶KIX∶c-Myb ternary complex, its binary components and KIX with the goal of providing a mechanistic explanation for the experimental observations. The dynamic behavior revealed that the MLL binding site is allosterically coupled to the c-Myb binding site. MLL binding redistributes the conformational ensemble of KIX, leading to higher populations of states which favor c-Myb binding. The key element in the allosteric communication pathways is the KIX loop, which acts as a control mechanism to enhance subsequent binding events. We tested this conclusion by in silico mutations of loop residues in the KIX∶MLL complex and by comparing wild type and mutant dynamics through MD simulations. The loop assumed MLL binding conformation similar to that observed in the KIX∶c-Myb state which disfavors the allosteric network. The coupling with c-Myb binding site faded, abolishing the positive cooperativity observed in the presence of MLL. Our major conclusion is that by eliciting a loop-mediated allosteric switch between the different states following the binding events, transcriptional activation can be regulated. The KIX system presents an example how nature makes use of conformational control in higher level regulation of transcriptional activity and thus cellular events.

Indexed as

Models, ChemicalModels, MolecularTranscriptional ActivationBinding SitesComputer SimulationCREB-Binding ProteinHistone-Lysine N-MethyltransferaseMyeloid-Lymphoid Leukemia ProteinProtein BindingProtein ConformationProtein Structure, TertiaryProto-Oncogene MasProto-Oncogene Proteins c-mybCREB-Binding ProteinCREBBP protein, humanHistone-Lysine N-MethyltransferaseKMT2A protein, humanMAS1 protein, humanMyeloid-Lymphoid Leukemia ProteinProto-Oncogene MasProto-Oncogene Proteins c-myb

Identifiers

PMID22438798
PMCPMC3305381

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.